Pharmacyte Biotech Inc. (PMCB)
NASDAQ · Healthcare
Pharmacyte Biotech Inc. Net Income 2011–2025
Pharmacyte Biotech Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Pharmacyte Biotech Inc. net income for the quarter ending January 31, 2026 was 746860, a 124.52% decrease year-over-year.
- Pharmacyte Biotech Inc. net income for the twelve months ending January 31, 2026 was -18.1 M, a 174.94% decrease year-over-year.
- Pharmacyte Biotech Inc. annual net income for 2025 was 30.7 M, a 9084.98% increase from 2024.
- Pharmacyte Biotech Inc. annual net income for 2024 was 333763, a 107.73% decrease from 2023.
- Pharmacyte Biotech Inc. annual net income for 2023 was -4.3 M, a 1.81% increase from 2022.
- Pharmacyte Biotech Inc. annual net income for 2022 was -4.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pharmacyte Biotech Inc. Net Income — FAQ
Pharmacyte Biotech Inc. (PMCB) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Pharmacyte Biotech Inc.'s net income?
Pharmacyte Biotech Inc. (PMCB) reported net income of $31M for fiscal 2025.
Where can I see PMCB's net income history?
The chart and table above show Pharmacyte Biotech Inc.'s net income by year and by quarter, including the growth rate.